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An ab initio approach was used to study the molecular-level interactions that connect gene-mutation to
changes in an organism's phenotype. The study provides new insights into the evolutionary process and
presents a simpliﬁcation whereby changes in phenotypic properties may be studied in terms of the
binding afﬁnities of the chemical interactions affected by mutation, rather than by correlation to the
genes. The study also reports the role that nonlinear effects play in the progression of organs, and how
those effects relate to the classical theory of evolution. Results indicate that the classical theory of
evolution occurs as a special case within the ab initio model – a case having two attributes. The ﬁrst
attribute: proteins and promoter regions are not shared among organs. The second attribute: continuous
limiting behavior exists in the physical properties of organs as well as in the binding afﬁnity of the
associated chemical interactions, with respect to displacements in the chemical properties of proteins
and promoter regions induced by mutation. Outside of the special case, second-order coupling con-
tributions are signiﬁcant and nonlinear effects play an important role, a result corroborated by analyses
of published activity levels in binding and transactivation assays. Further, gradations in the state of
perfection of an organ may be small or large depending on the type of mutation, and not necessarily
closely-separated as maintained by the classical theory. Results also indicate that organs progress with
varying degrees of interdependence, the likelihood of successful mutation decreases with increasing
complexity of the affected chemical system, and differences between the ab initiomodel and the classical
theory increase with increasing complexity of the organism.
& 2016 The Author. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The purpose of this study is to derive and evaluate an ab initio
model of evolution in order to explore the associated chemical
reactions at the molecular level, and thereby provide insight into
the relationship between changes in an organism's genetic code and
changes in its phenotype. The ab initio approach enables funda-
mental relationships between mutation and phenotype to be cast inLtd. This is an open access articlea basic mathematical form, thereby enabling quantitative assess-
ment of the associated nonlinear effects. The nonlinear effects arise
from non-negligible contributions of interdependencies within the
associated chemical processes.
Many types of interdependencies between organs and proteins
are observed empirically. For example, the brain depends on many
proteins such as Contactin-1 (CNTN1), α1-Syntrophin (SNTA1), γ1-
Syntrophin (SNTG1), and γ2-Syntrophin (SNTG2), among others,
where gene designation is parenthesized (UNIPROT). Some pro-
teins are singly-located, such as γ1-Syntrophin (SNTG1) which is
found only in the brain. Other proteins, such as α1-Syntrophin
(SNTA1), sine oculis (SIX1) and the heart-type fatty acid bindingunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
D.G. Clerc / Journal of Theoretical Biology 401 (2016) 94–108 95protein (FABP3) are found in many locations. Snta1 has high levels
of expression in skeletal muscle and the heart, as well as low levels
of expression in the brain, kidney, pancreas, liver and lungs
(UNIPROT). In mice, Six1 is present in the olfactory system, sta-
toacoustic system, pituitary gland, thymus, various muscle groups,
tendons, and connective tissue (Laclef et al., 2003). Fabp3 is pre-
sent in many cell types, such as heart, skeletal muscle, brain,
kidney, lung and stomach, among others (Furuhashi and Hota-
misligil, 2008). Another example of interdependence is the liver,
which manufactures approximately 80% of all amino acids used in
the body. Mutations that affect the SNTA1, SIX1 or FABP3 genes, or
the liver, thus have the potential to affect multiple organs.
Activation of a protein can potentially be affected by mutations
in several locations, given that regulatory processes are associated
with multi-body interactions. For example, in order for transcrip-
tion to commence in eukaryotes, a collection of transcription fac-
tor (TF) proteins attach to a gene's promoter region, often as
homo-dimers or heterodimers, followed by the binding of RNA
polymerase to the collection, to form a transcription initiation
complex bound to the promoter site of the protein's gene. A pro-
tein's transcription is thus affected by mutations to associated TFs
and co-activators that affect their ability to form the transcription
initiation complex. Further, TFs possess a zone that binds to DNA,
and a mutation to that zone is capable of changing the TF's ability
to bind directly to the gene's activation site. Thus changes in a
protein's regulation depend not only on mutations within the
promoter segments of its own gene, but also on mutations to the
zone of a TF that attaches to the promoter region, and on muta-
tions within the coding and promoter segments in the genes of its
other TFs.
Epistatic processes (gene-gene interactions) involve inter-
dependencies as well, through the capability of one mutation to
affect multiple organs and multiple chemical processes. In an
epistatic process, mutation to one gene and its associated protein
affects all related downstream organs, and overrides or masks the
effects that mutations to downstream genes would ordinarily
have. For example, a mutation in the liver could indirectly affect
any organ that employs the amino acids that the liver generates. A
gene associated with those particular organs would thereby be
masked by the mutation to the liver. Another example is the
mutation that causes albinism, which overrides the mutation that
affects eye color.
This study differs fundamentally in its methodology from other
mathematical theories of evolution, which have generally treated
the process from a more macroscopic perspective. For example,
quantitative genetics treats changes in phenotypic traits statisti-
cally, both within and between populations, as they relate to both
genotypic and environmental factors (Walsh, 2001). One-locus and
two-locus models involve the analysis of factors such as gamete
characteristics and allele frequencies, among others, in order to
evaluate the evolution of populations over time (Yanchukov,
2009). Coalescent theory involves tracing all alleles of a gene
shared by members of a population to a single ancestral copy,
known as the most recent common ancestor (Kingman, 1982a,
1982b, 1981). Evolutionary game theory involves analyzing the
strategies employed in a competing population to survive and
reproduce (Sandholm, 2007). Thus, this study differs in its
approach compared to current theories, owing to its focus on
chemical interactions at the molecular-level.
The term ab initio, whose literal meaning is “from the begin-
ning”, is used to describe this study given that it relates changes in
phenotypic properties to molecular-level quantities which are
derivable from ﬁrst principles and calculable using the rigorous
computational techniques of quantum chemistry. Ab initio meth-
odology is therefore adhered to in this study, that is relying on
established laws of nature without introducing assumptions. Assuch, scientiﬁc observations that have been thoroughly corrobo-
rated over long periods of time, to such an extent that they are
currently considered self-evident, are considered established laws
of nature. Examples include the dependence of an organ's physical
properties on the proteins that comprise it, and the dependence of
a protein's chemical composition on its encoding gene. External
inﬂuences on the organism are not considered – such as climate,
availability of food sources, group behavior, communication, and
so forth. Focus is placed on the mutations that are transmitted to
offspring, such as germ-line mutations in animals, and upon the
associated chemical mechanisms whereby those mutations affect
the phenotype of the offspring, at the level of ﬁrst-principles.2. Results
Results are reported in three sections. Initially, expressions that
relate mutation of genes to changes in phenotype are derived.
Second, the resultant expressions are compared to laboratory data
to assess the level of coupling contributions. Lastly, the ab initio
model is compared to the classical theory of evolution.
A number of terms are adopted in this study. The term “phe-
notype” refers to the physical and biochemical state of an organ-
ism, and “physical property” refers to macroscopic properties as
well as biochemical properties. The term “protein” is used gener-
ically throughout to refer not only to a type of protein per se, but
also to other types of compounds such as hormones, enzymes, and
other protein-derivatives. The term “residue” denotes an amino
acid residue in a protein, “nucleotide” denotes a nucleotide in the
promoter region of a gene, and “entity” refers to either a residue or
a nucleotide. Lastly, the term “organ” in a mathematical context
refers to a collection of the physical properties of a biological
system component.3. Theory
In the following discussion, coding-region mutations which
alter the composition of the corresponding protein are considered,
such as a missense mutation whose transcription yields a different
amino acid residue in the associated protein. Also considered are
mutations to promoter regions, which alter production of the
corresponding protein, such as a alteration of a nucleotide that
affects binding to transcription factors. Deﬁnitions of all central
variables are listed in the supplemental portion of this study
(Supplementary material – Part S.1). All assertions are enumerated
in this section, along with their associated mathematical expres-
sions, as follows.
3.1. A mutation that alters the composition of a gene in its coding or
promoter region, respectively affects the chemical properties of resi-
dues in its associated protein, or nucleotides in its promoter region
A mutation in the coding region of a gene that yields a change
of composition in its corresponding protein, effectively replaces
one type of residue with one or more different types of residues.
Similarly, a mutation in the promoter region of a gene affects the
chemical composition of the nucleotides there. As a result, the
associated displacement of a chemical property at that location
may be represented as follows,
ΔπðI;p-qÞrm ¼ πðIÞrmjq πðIÞrmjp: ð1Þ
Here, πðIÞrm denotes the mth chemical property of the rth entity.
The terms πðIÞrmjp and πðIÞrmjq denote a chemical property of the ori-
ginal and modiﬁed entity, respectively. Superscripted indices
within parentheses denote parametric dependence. For example,
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mutation in SNAP25 whereby residue type T (threonine) at posi-
tion 138 is replaced with E (glutamic acid). The parameter I
denotes the set of indices fg; k; ig, where g; k; i are deﬁned in more
detail in the discussion that follows - referring to generation (g),
physical property (k) and binding interaction type (i). Example
chemical properties include dipole moment, polarizability, elec-
tron afﬁnity, and ionization potential, among others.
3.2. Chemical properties of participating entities intrinsically relate
to the binding afﬁnity of interacting proteins and promoter regions
The chemical properties of the residues within a protein or a
protein-complex, and the chemical properties of the nucleotides in
the gene's promoter region, fundamentally relate to reactive
properties such as the binding afﬁnity of interacting proteins and
promoter regions. This assertion may be rigorously established by
solving the Schrőedinger equation computationally for a set of
interacting proteins, to show that changes in the chemical prop-
erties of participating entities affect the binding afﬁnity of the
interaction. Electronic properties at the binding sites, such as the
dipole moment or polarizability, contribute toward the ability of
entities to form bonds with one another. As such, binding afﬁnity
may be written as a function of the chemical properties of all
interacting entities, as follows.
Bðg;kÞi  B
ðg;kÞ
i π
ðIÞ
1;1; π
ðIÞ
1;2; … ; π
ðIÞ
1;NðI;1Þcp
;

πðIÞ2;1; π
ðIÞ
2;2; … ; π
ðIÞ
2;NðI;2Þcp
;
… ;
πðIÞ
NðIÞe ;1
; πðIÞ
NðIÞe ;2
; … ; πðIÞ
NðIÞe ;N
ðI;Ne Þ
cp

ð2Þ
Here, πðIÞrm denotes the mth chemical property of the rth entity
associated with the ith kind of binding interaction, NðI;rÞcp is the
number of chemical properties of the rth entity, and NðIÞe is the total
number of entities across all proteins and promoter regions
associated with this kind of interaction. For example, interactions
between proteins Synaptobrevin and Syntaxin constitute one kind
of protein-protein interaction, whereas interactions between
Synaptobrevin and Six1 constitute a different kind of protein-
protein interaction. Activation-related interactions – interactions
between a protein or protein-complex and a promoter region of a
gene – are also included in Eq. (2), such as binding between the
promoter of the GDNF gene and the Six1 protein.
3.3. Binding afﬁnities intrinsically relate to the physical properties of
a biological system
Chemical reactions between proteins and other proteins, and
between proteins and promoter regions, are central to the for-
mation and operation of various organs. For example, such reac-
tions establish chemical bonds that comprise and interconnect
muscle ﬁbers, which in turn determine the elastic stiffness of
muscle ﬁbers. Similarly, such reactions establish the electronic
properties of the receptor sites that bind to calcium ions, which in
turn govern the rate of muscle contraction. Each physical property
is dependent upon an associated chemical reaction and in parti-
cular upon the binding events of its associated reaction mechan-
ism. Thus the kth physical property PðgÞk of a biological system is
dependent upon the binding afﬁnities of its various associated
chemical reactions, and may be expressed as follows,
PðgÞk ¼ P
ðgÞ
k B
ðg;kÞ
1 ; B
ðg;kÞ
2 ;…;B
ðg;kÞ
Nðg;kÞ
b
 
: ð3ÞThe quantity Bðg;kÞi measures the afﬁnity of the i
th kind of
binding interaction of Nðg;kÞb total kinds of interactions associated
with the kth physical property.
3.4. Physical properties of the biological systems determine an
organism's phenotype
In humans, for example, the biological systems are twelve in
number: circulatory, digestive, skin, muscular, nervous, reproduc-
tive, respiratory, skeletal, urinary, hormonal, immune, and lym-
phatic. Each of these biological systems contains various compo-
nents, such as heart, brain, lungs, skin, and so forth – each of
which is characterized by many physical properties. Each physical
property is primarily based on chemical composition and chemical
reaction kinetics. Example properties that derive from chemical
composition include mechanical stiffness of cardiac tissue, aniso-
tropy of heart-valve tissue, elastic stiffness of muscle ﬁber, fracture
toughness of skeletal tissue, bifurcation frequency within neural
networks, and so forth. Example rate-dependent properties
include conduction velocity of nerve ﬁbers, muscle response rate,
heart rate, respiratory rate, and so forth. An organism's phenotype
during the gth generation, Ψ g , is represented by the set of all such
properties as follows
Ψ g  PðgÞ1 ; PðgÞ2 ; …; PðgÞNðgÞ
k
 
; ð4Þ
where PðgÞk denotes the k
th physical property of NðgÞk total physical
properties across all biological systems. The physical properties
PðgÞk in Eq. (4) may interrelate through dependence on common
binding interactions Bðg;kÞi in Eq. (3).
3.5. Changes in Bðg;kÞi and P
ðgÞ
k induced by gene mutation may be
expressed in quadratic form, in terms of displacement in the chemical
properties of mutated entities
The following deﬁnitions denote changes in Bðg;kÞi , P
ðgÞ
k and Ψ g in
terms of a general gene transition p-q.
ΔBðg;k;p-qÞi ¼ B
ðg;kÞ
i jqB
ðg;kÞ
i jp ð5Þ
ΔPðg;p-qÞk ¼ P
ðgÞ
k jqP
ðgÞ
k jp ð6Þ
ΔΨ ðp-qÞg ¼ ΔPðg;p-qÞ1 ;ΔPðg;p-qÞ2 ;…;ΔPðg;p-qÞNðgÞ
bp
 
ð7Þ
The binding afﬁnities on the right-hand side of Eq. (5) appeared
in Eq. (2) as multivariate functions of chemical properties πðIÞrm,
indexed by entity rAf1; 2;…; NðIÞe g and chemical property
mAf1; 2;…; NðI;rÞcp g. Changes in binding afﬁnity thus may be
written as a Taylor series, in terms of changes in
ΔBðg;k;p-qÞi ¼
XNðIÞe
r ¼ 1
XNðI;rÞcp
m ¼ 1
cðIÞrmΔπ
ðI;p-qÞ
rm
þ1
2
XNðIÞe
r ¼ 1
XNðIÞe
s ¼ 1
XNðI;rÞcp
m ¼ 1
XNðI;sÞcp
n ¼ 1
cðIÞrmsn Δπ
ðI;p-qÞ
rm Δπ
ðI;p-qÞ
sn
þ1
6
XNðIÞe
r ¼ 1
XNðIÞe
s ¼ 1
XNðIÞe
t ¼ 1
XNðI;rÞcp
m ¼ 1
XNðI;sÞcp
n ¼ 1
XNðI;tÞcp
p ¼ 1
cðIÞrmsntp Δπ
ðI;p-qÞ
rm
ΔπðI;p-qÞsn ΔπðI;p-qÞtp þ… ð8Þ
Coefﬁcient cðIÞrm is ordinarily the ﬁrst partial derivative of B
ðg;kÞ
i
with respect to πðIÞrm, coefﬁcient c
ðIÞ
rmsn is ordinarily the second partial
derivative of Bðg;kÞi with respect to π
ðIÞ
rm and π
ðIÞ
sn, and so forth. In this
study, the relationship between Bðg;kÞi and π
ðIÞ
rm is not assumed to be
continuous, an assumption that could inaccurately allow dis-
placements to be arbitrarily small. Instead, the derivatives are
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tered ﬁnite difference quotients.
cðIÞrm ¼
Bðg;kÞi ðπ
ðIÞ
rmþh0rmÞBðg;kÞi ðπ
ðIÞ
rmh00rmÞ
h0rmþh00rm

o
ð9ÞcðIÞrmsn ¼
Bðg;kÞi ðπ
ðIÞ
rmþh0rmþk0rmÞBðg;kÞi ðπ
ðIÞ
rmþh0rmk00rmÞ
Bðg;kÞi ðπ
ðIÞ
rmh00rmþk0rmÞþBðg;kÞi ðπ
ðIÞ
rmh00rmk00rmÞ
h0rmþh00rm
 
k0rmþk00rm
 

o
r¼ s; m¼ n
Bðg;kÞi ðπ
ðIÞ
rmþh0rm;πðIÞsnþk0snÞBðg;kÞi ðπ
ðIÞ
rmþh0rm;πðIÞsnk00snÞ
Bðg;kÞi ðπ
ðIÞ
rmh00rm;πðIÞsnþk0snÞþBðg;kÞi ðπ
ðIÞ
rmh00rm;πðIÞsnk00snÞ
ðh0rmþh00rmÞðk0snþk00snÞ

o
ras; r¼ s; man
8>>>>>>>>><
>>>>>>>>>:
ð10ÞThus continuous and limiting behavior, if present, would follow
from analysis of the quotients with respect to magnitude of dis-
placement. For clarity, chemical properties that are held constant
in the quotients are not explicitly listed. Subscript “o” on the ver-
tical bars denote a point of reference which is genes po and qo
associated with the original chemical properties of entities r and s,
respectively. Displacements h0rm and h
00
rm denote changes in the
chemical properties of entity r corresponding to distinct mutations
p0 and p00 of the gene or promoter region associated with entity r.
Similarly, displacements k0sn and k
00
sn denote changes in the che-
mical properties of entity s corresponding to distinct mutations q0
and q00 of the gene or promoter region associated with entity s.
Eqs. (8)–(10) may be simpliﬁed by recasting the coefﬁcients in
terms of changes in binding afﬁnity and changes in chemical
properties induced by mutation. Further details are reported in the
supplemental portion of this study (Supplementary material – Part
S.2). Omitting third- and higher-order terms for reasons of brevity,
the resultant expression is as follows,
ΔBðg;k;p-qÞi ¼
XNðIÞe
r ¼ 1
XNðI;rÞcp
m ¼ 1
cðIÞrmΔπ
ðI;p-qÞ
rm
þ1
2
XNðIÞe
r ¼ 1
XNðIÞe
s ¼ 1
XNðI;rÞcp
m ¼ 1
XNðI;sÞcp
n ¼ 1
cðIÞrmsnΔπ
ðI;p-qÞ
rm Δπ
ðI;p-qÞ
sn : ð11Þ
Coefﬁcients cðIÞrm and c
ðIÞ
rmsn are constant across the mutations
associated with generation g, property k and interaction i, and are
equivalents to Eqs. (9) and (10) having the following deﬁnitions.
cðIÞrm ¼
ΔBðg;k;p
00→poÞ
i þ ΔB
ðg;k;po→p′Þ
i
ΔπðI;p
00→poÞ
rm þ ΔπðI;po→p′Þrm
ð12ÞcðIÞrmsn ¼
ΔBðg;k;p
0-q0 Þ
i ΔB
ðg;k;p0-q00 Þ
i ΔB
ðg;k;p00-q0 Þ
i þΔB
ðg;k;p00-q00 Þ
i
ðΔπðI;p00-poÞrm þΔπðI;po-p
0 Þ
rm ÞðΔπðI;q
00-qoÞ
rm þΔπðI;qo-q
0 Þ
rm Þ
r¼ s;m¼ n
ΔBðg;k;poqo-p
0q0 Þ
i ΔB
ðg;k;poqo-p0q00 Þ
i ΔB
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i
ðΔπðI;p00-poÞrm þΔπðI;po-p
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rm Þ ðΔπðI;q
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sn þΔπðI;qo-q
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sn Þ
ras; r¼ s; man
8>><
>>:
ð13ÞEq. (11) thus enables changes in binding afﬁnity to be deter-
mined, for an arbitrary mutation, based on the relatively small set
of mutations necessary to evaluate cðIÞrm and c
ðIÞ
rmsn through Eqs. (12)
and (13).Similarly, the change of physical properties in Eq. (6) depends
on the change in binding afﬁnity of its associated chemical reac-
tions. As a result, ΔPðg;p-qÞk may be expressed in terms of ΔB
ðg;k;p-qÞ
i
(Supplementary material – Part S.3). The resultant expression tosecond-order is as follows,
ΔPðg;p-qÞk ¼
XNðg;kÞb
i ¼ 1
bðg;kÞi ΔB
ðg;k;p-qÞ
i þ
1
2
XNðg;kÞb
i ¼ 1
XNðg;kÞb
j ¼ 1
bðg;kÞij ΔB
ðg;k;p-qÞ
i ΔB
ðg;k;p-qÞ
j
ð14Þ
where coefﬁcients bðg;kÞi and b
ðg;kÞ
ij are constant across the mutations
associated with generation g and property k deﬁned in the fol-
lowing manner. (Supplementary material – Eq. (S.3.5))
bðg;kÞi ¼
ΔPðg;p
00→poÞ
k þ ΔP
ðg;po→p′Þ
k
ΔBðg;k;p
00→poÞ
i þ ΔB
ðg;k;po→p′Þ
i
ð15Þ
bðg;kÞij ¼
ΔPðg;p
0-q0 Þ
k
ΔPðg;p0-q00 Þ
k
ΔPðg;p00-q
0 Þ
k
þΔPðg;p00-q00 Þ
k
ðΔBðg;k;p00-po Þi þΔB
ðg;k;po-p0 Þ
i ÞðΔB
ðg;k;q00-qo Þ
i þΔB
ðg;k;qo-q0 Þ
i Þ
i¼ j
ΔPðg;poqo-p
0q0 Þ
k
ΔPðg;poqo-p0q00 Þ
k
ΔPðg;poqo-p00q0 Þ
k
þΔPðg;poqo-p00q00 Þ
k
ðΔBðg;k;p00-po Þi þΔB
ðg;k;po-p0 Þ
i Þ ðΔB
ðg;k;q00-qo Þ
j þΔB
ðg;k;qo-q0 Þ
j Þ
ia j
8>><
>>:
ð16Þ
Eq. (14) thus enables changes in a physical property to be
determined, for an arbitrary mutation, based on the relatively
small set of mutations necessary to evaluate bðg;kÞi and b
ðg;kÞ
ij through
Eqs. (15) and (16). Eq. (14) also formally relates ΔPðg;p-qÞk to
ΔBðg;k;p-qÞi -a quantity that is calculable at the level of ﬁrst-
principles.
Two of the above expressions may be combined to yield the
change in a physical property in terms of change in entities' che-
mical properties. Substituting Eq. (11) into Eq. (14) yields the
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ΔPðg;p-qÞk ¼
XNðg;kÞb
i ¼ 1
bðg;kÞi
XNðIÞe
r ¼ 1
XNðI;rÞcp
m ¼ 1
cðIÞrm Δπ
ðI;p-qÞ
rm
þ1
2
XNðg;kÞb
i ¼ 1
bðg;kÞi
XNðIÞe
r ¼ 1
XNðIÞe
s ¼ 1
XNðI;rÞcp
m ¼ 1
XNðI;sÞcp
n ¼ 1
cðIÞrmsnΔπ
ðI;p-qÞ
rm Δπ
ðI;p-qÞ
sn
þ1
2
XNðg;kÞb
i ¼ 1
XNðg;kÞb
j ¼ 1
bðg;kÞij
XNðIÞe
r ¼ 1
XNðJÞe
s ¼ 1
XNðI;rÞcp
m ¼ 1
XNðJ;sÞcp
n ¼ 1
cðIÞrmc
ðJÞ
sn Δπ
ðI;p-qÞ
rm Δπ
ðJ;p-qÞ
sn ð17Þ
Eqs. (11) and (17) thus represent changes in Bðg;kÞi and P
ðgÞ
k as
quadratic functions of displacement in the chemical properties
associated with mutation. Within both equations, the ﬁrst term is
linear whereas the other terms represent second-order pairwise
interactions. Indices r and s run across all entities, m and n run
across the chemical properties associated with the entities, i and j
run across all types of binding interactions between entities, k
runs across the physical properties of all biological systems, set
I¼ fg; k; ig, set J ¼ fg; k; jg and g denotes the generation.
Evaluation of Eqs. (11)–(17) may be accomplished by combining
computation and measurement. For example, ab initio computa-
tion may be employed to calculate ΔBðg;k;p-qÞi and Δπ
ðI;p-qÞ
rm .
Laboratory measurement may be employed to determine relative
values of ΔBðg;k;p-qÞi , and may be the primary source of data for
ΔPðg;p-qÞk . The precision of ΔB
ðg;k;p-qÞ
i and ΔP
ðg;p-qÞ
k depends upon
the conﬁdence limits of Eqs. (11), (14) and (17), that in turn
depends on the values and precision of the measured or computed
quantities therein as well as on the complexity of the mutated
chemical system. Similarly, precision of cðIÞrm, c
ðIÞ
rmsn, b
ðg;kÞ
i and b
ðg;kÞ
ij
depends on the conﬁdence limits of Eqs. (12), (13), (15) and (16),
that in turn also depends on the values and precision of the
measured or computed quantities therein, as well as on the par-
ticular set of mutations used to evaluate those expressions. Pre-
cision and rigor associated with ΔPðg;p-qÞk are inﬂuenced depend-
ing upon whether P is expressed as a function of B in Eq. (3) using
two sets of indices, or whether indices are consolidated into one
group and P is expressed directly as a function of π. Expressing P
as a function of B in Eq. (3) has a signiﬁcant advantage owing to
the existence of a rigorous lower bound on the total energy of aFig. 1. Relationships between changes in the phenotype (ΔΨ, top) and gene mutation (
outer rectangle (dashed line). The shaded inner rectangle represents chemical proces
associate changes in the binding afﬁnity of a particular interaction (ΔB) to changes in t
shaded rectangle but within the outer rectangle represents the dependence of changes
property to the binding afﬁnity of its associated chemical interactions. That particular a
lations, although empirical or semi-empirical methods may be used instead to relate ΔP
The mapping between p-q and Δπ is depicted as 1:1 for simplicity – as a single muta
Subscripted indices are deﬁned in the text, aside from Nm which denotes the number ochemical interaction. Changes in the total energy, induced by
compositional changes, are directly related to the changes in
binding afﬁnity focused upon this study. As a result, ΔπðI;p-qÞrm may
be systematically varied to yield values of ΔBðg;k;p-qÞi that even-
tually converge to their lower bounds, at which point ΔPðg;p-qÞk
could be studied in terms of the converged ΔBðg;k;p-qÞi . Such mat-
ters are discussed in more detail within the supplemental portion
of this study (Supplementary material – Part S.4).3.6. The change in phenotype over the course of time is the accu-
mulation of all incremental changes that occur during each
generation
The total change in an organism's phenotype ΔΨ over the
course of Ng generations is set of all changes in physical properties
that occur during each generation as follows,
ΔΨ  fΔP1; ΔP2; …; ΔPNg g ð18Þ
where
ΔPk ¼
XNg
g ¼ 1
ΔPðg;pg-qg Þk : ð19Þ
Here, the mutation that occurs during the gth generation is
denoted by pg-qg . For example, a mutation may cause the elastic
stiffness of a particular set of muscle ﬁbers to increase by 0.2 MPa
in the ﬁrst generation, and a subsequent mutation may cause that
property to decrease by 0.5 MPa in the second generation, and so
on. Substituting Eq. (17) into Eq. (19) yields the following
expression for the accumulated change in the kth physical prop-
erty.
ΔPk ¼
XNg
g ¼ 1
XNðg;kÞb
i ¼ 1
bðg;kÞi
XNðIÞe
r ¼ 1
XNðI;rÞcp
m ¼ 1
cðIÞrm Δπ
ðI;pg-qg Þ
rm
þ1
2
XNg
g ¼ 1
XNðg;kÞb
i ¼ 1
bðg;kÞi
XNðIÞe
r ¼ 1
XNðIÞe
s ¼ 1
XNðI;rÞcp
m ¼ 1
XNðI;sÞcp
n ¼ 1
cðIÞrmsn Δπ
ðI;pg-qg Þ
rm Δπ
ðI;pg-qg Þ
snp-q, bottom) are depicted schematically. The ab inito model operates within the
ses which can be studied using ab initio computational techniques; dotted lines
he chemical properties of its associated proteins (Δπ). The area that lies above the
in phenotypic physical properties (ΔP) upon ΔB; dashed lines associate a particular
rea is probably not sufﬁciently understood at this time to conduct ab initio calcu-
to ΔB. The relative number of p-q, Δπ, ΔB and ΔP are for illustrative purposes only.
tion could, in principle, affect more than one chemical property of a given residue.
f gene mutations.
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2
XNg
g ¼ 1
XNðg;kÞb
i;j ¼ 1
bðg;kÞij
XNðIÞe
r ¼ 1
XNðJÞe
s ¼ 1
XNðI;rÞcp
m ¼ 1
XNðJ;sÞcp
n ¼ 1
cðIÞrmc
ðJÞ
sn Δπ
ðI;pg-qg Þ
rm Δπ
ðJ;pg-qg Þ
sn
ð20Þ
Similarly, the total change in a particular binding afﬁnity may
be obtained by accumulating the changes in the individual binding
afﬁnities, as follows.
ΔBðkÞi ¼ ∑
Ng
g ¼ 1
ΔB
ðg;k;pg→qg Þ
i ð21Þ
Substituting Eq. (11) into Eq. (21) yields the accumulated
change in binding afﬁnity.
ΔBðkÞi ¼
XNg
g ¼ 1
XNðIÞe
r ¼ 1
XNðI;rÞcp
m ¼ 1
cðIÞrmΔπ
ðI;pg-qg Þ
rm
þ1
2
XNg
g ¼ 1
XNðIÞe
r ¼ 1
XNðIÞe
s ¼ 1
XNðI;rÞcp
m ¼ 1
XNðI;sÞcp
n ¼ 1
cðIÞrmsn Δπ
ðI;pg-qg Þ
rm Δπ
ðI;pg-qg Þ
sn ð22Þ
For example, accumulated changes in binding afﬁnity may
occur through a successive change of the dipole moment, such as
in some interacting residue A in generation 1, in some interacting
residue B in generation 2, and so on.
The relationship between change in phenotype, the corre-
sponding gene mutations, and the ab initio model which includes
ΔPðg;p-qÞk , ΔB
ðg;k;p-qÞ
i and Δπ
ðI;p-qÞ
rm , is illustrated in Fig. 1. The ab
initio model enables a simpliﬁcation whereby ΔBðg;k;p-qÞi and Δ
πðI;p-qÞrm may be computed and related. As a result, changes in
phenotypic properties ΔPðg;p-qÞk may be studied in terms of com-
puted ΔBðg;k;p-qÞi instead of Δπ
ðI;p-qÞ
rm or gene mutation, thereby
removing interdependencies between ΔBðg;k;p-qÞi and Δπ
ðI;p-qÞ
rm
from the study of ΔPðg;p-qÞk .
3.7. Example scenarios: Eqs. (11) and (14)
The following examples illustrate scenarios under which Eqs.
(11) and (14) may be applied. In these scenarios, the chemical
property most often employed is the dipole moment, given the
observation that electrostatic interactions among amino acid
residues, such as H-bonding, often provide binding within DNA
strands and dominate in protein-protein interactions. Consider the
scenario shown in Fig. 2, in which mutation p- q affects binding
between proteins X, Y and Z through modiﬁcation of protein Z. In
protein Z, structures or residues Z1 and Z3 change according to Z1
- Z10 and Z3- Z30, thus affecting binding interactions Z1-X2, Z1-
X3 and Z3-Y3.Fig. 2. Effects of mutation are shown for a generalized interaction between pro-
teins X, Y and Z, as associated with gene “p” (left-hand side) and gene “q” (right-
hand side). Residues on protein X are labeled X1, X2 and X3; those on protein Y are
Y1, Y2, Y3 and Y4, and structures or residues on protein Z are Z1, Z2, Z3 and Z4,
where Z0 represents a central structure such as a protein backbone. Structures
affected by the mutation are labeled Z10 and Z30 . Dashed lines denote binding
interactions.According to Eq. (11), change in the binding afﬁnity of proteins
X, Y and Z is a function of changes in the molecular-level chemical
properties that derive the interactions shown in Fig. 1. Such che-
mical properties include those which align the molecules such that
each protein's reactive sites become proximate - such as local
dipole moments; as well as those which stabilize the X-Y-Z com-
plex through formation of ionic or covalent bonds – such as dipole
moment, polarizability and local valence electron population.
Consider the case where alignment and stabilization of the X–
Y–Z complex occurs primarily through dipole-dipole interactions.
In this scenario, binding between proteins Z and X can be repre-
sented by a dipole in protein Z at Z1 that interacts with dipoles in
protein X at X2 and X3, along the Z1-X2 and Z1-X3 bond axes. In
terms of Eq. (11), changes in binding afﬁnity at Z1 thus depend on
changes in the dipole moment at Z1 induced by mutation. The
total change in binding afﬁnity may be written as follows
ΔBðg;k;p-qÞXYZ ¼ cðIÞZ1;μΔπðI;p-qÞZ1;μ þ
1
2
cðIÞZ1;μ;Z1;μ Δπ
ðI;p-qÞ
Z1;μ
	 
2
þcðIÞZ3;μΔπðI;p-qÞZ3;μ þ
1
2
cðIÞZ3;μ;Z3;μ Δπ
ðI;p-qÞ
Z3;μ
	 
2
þcðIÞZ1;μ;Z3;μΔπðI;p-qÞZ1;μ ΔπðI;p-qÞZ3;μ ; ð23Þ
where set I ¼ fg; k;XYZg and μ denotes the dipole moment.
Coefﬁcients cðIÞZ1;μ and c
ðIÞ
Z1;μ;Z1;μ measure interactions between Z1
and its binding partners X2 and X3; coefﬁcients cðIÞZ3;μ and c
ðIÞ
Z3;μ;Z3;μ
measure interactions between Z3 and Y3; coefﬁcient cðIÞZ1;μ;Z3;μ
measure interdependencies between Z1 and Z3. Displacements in
chemical properties are deﬁned through Eq. (1) as
ΔπðI;p-qÞZ1;μ ¼ μZ1jqμZ1jp ¼ μZ10 μZ1; ð24Þ
ΔπðI;p-qÞZ3;μ ¼ μZ3jqμZ3jp ¼ μZ30 μZ3; ð25Þ
where superscripts on the chemical properties have been omitted
for brevity. In the case where p - q induces chirality, such as
Z10 ¼Z3 and Z30 ¼Z1, the above displacements may be written as
ΔπðI;p-qÞZ1;μ ¼ μZ3μZ1 ð26Þ
ΔπðI;p-qÞZ3;μ ¼ μZ1μZ3; ð27Þ
and Eq. (23) takes the following form.
ΔBðg;k;p-qÞXYZ ¼ ½cðIÞZ1;μcðIÞZ3;μðμZ3μZ1Þ
þ 1
2
cðIÞZ1;μ;Z1;μþ
1
2
cðIÞZ3;μ;Z3;μcðIÞZ1;μ;Z3;μ
 
ðμZ3μZ1Þ2 ð28Þ
In the case where p - q induces only a deletion, such as the
disappearance of Z1, the site Z10 has μZ1' ¼ 0. A similar result
occurs when the mutation yields a nonpolar residue at Z10. In both
cases, the result may be written as follows.
ΔπðI;p-qÞZ1;μ ¼ 0μZ1 ¼ μZ1 ð29Þ
ΔBðg;k;p-qÞXYZ ¼ cðIÞZ1;μμZ1þ
1
2
cðIÞZ1;μ;Z1;μμZ1
2 ð30Þ
Consider the case where a mutation affects an upstream pro-
cess that in turn affects the reaction in Fig. 2, for example by
stopping the generation of protein Z. In that case, the reactive sites
at Z1, Z2 and Z3 would vanish and results analogous to Eq. (29)
would hold for each of those sites. Also induced by the mutation,
changes of binding afﬁnity within the upstream process would
also contribute to ΔPðg;p-qÞk . This scenario is further discussed in
the discussion of epitasis (Supplementary material, Part 6).
Another interesting case occurs when a mutation generates a
new binding entity Z5 (not shown in Fig. 1) that was either
inserted into the protein Z backbone, or substituted at the site of a
nonreactive entity. The change in binding afﬁnity in Eq. (23) would
Table 1
The effect of mutations in Snap25 on its binding afﬁnity to Stx1A and Syt1.
Mutation Change in binding afﬁnity (%) Change in phenotype
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ΔBðg;k;p-qÞXYZ ¼ cðIÞZ1;μΔπðI;p-qÞZ1;μ þ
1
2
cðIÞZ1;μ;Z1;μ Δπ
ðI;p-qÞ
Z1;μ
	 
2
þcðIÞZ3;μΔπðI;p-qÞZ3;μ þ
1
2
cðIÞZ3;μ;Z3;μ Δπ
ðI;p-qÞ
Z3;μ
	 
2
þcðIÞZ5;μΔπðI;p-qÞZ5;μ þ
1
2
cðIÞZ5;μ;Z5;μ Δπ
ðI;p-qÞ
Z5;μ
	 
2
þcðIÞZ1;μ;Z3;μΔπðI;p-qÞZ1;μ ΔπðI;p-qÞZ3;μ
þcðIÞZ1;μ;Z5;μΔπðI;p-qÞZ1;μ ΔπðI;p-qÞZ5;μ
þcðIÞZ3;μ;Z5;μΔπðI;p-qÞZ3;μ ΔπðI;p-qÞZ5;μ ð31Þ
where the change in chemical properties at Z5 corresponds to the
generation of a new bond dipole, as follows.
ΔπðI;p-qÞZ5;μ ¼ μZ50¼ μZ5 ð32Þ
Suppose that physical properties PðgÞk1 , such as anisotropy of
heart valve tissue, and PðgÞk2 , for example cardiac arterial wall
thickness, depend on the chemical reaction shown in Fig. 2. The
change in PðgÞk1 and P
ðgÞ
k2
owing to mutation p-q is as follows.
ΔPðg;p-qÞk1 ¼ b
ðg;k1Þ
XYZΔB
ðg;k1 ;p-qÞ
XYZ þ
1
2
bðg;k1ÞXYZ;XYZ ΔB
ðg;k1 ;p-qÞ
XYZ
	 
2
ð33Þ
ΔPðg;p-qÞk2 ¼ b
ðg;k2Þ
XYZΔB
ðg;k2 ;p-qÞ
XYZ þ
1
2
bðg;k2ÞXYZ;XYZ ΔB
ðg;k2 ;p-qÞ
XYZ
	 
2
ð34Þ
Computed or measured ΔBðg;k1 ;p-qÞXYZ may be substituted into Eqs.
(33) and (34) to obtain the change in physical properties. Coefﬁ-
cients bðg;kÞi and b
ðg;kÞ
ij would be evaluated from computed or mea-
sured data sets as described in the supplementary material (Sup-
plementary material – Part S.4).Snap25 to
Stx1Aa
Snap25 to
Syt1b
T138E 44710. 42712 Not available
S187E 77721 4576 Not available
T138EþS187E 79720. 3879 Not available
S187A 30.715 13712 Strong anxiety-related beha-
vior; occasional convulsive
seizuresc.
a Snap25 to Stx1A: Binding afﬁnities were calculated using the in vitro binding
assays reported in Yang et al. (2007) p. 240, Figs. 5A (S187A), 5B (T138E), 5C
(S187E), and 5D (T187EþS187E), which report the relative percent of binding for
both wild-type (WT) and mutated SNAP-25 to GST-Stx-1A as functions of Snap25
concentration. Changes in binding afﬁnity relative to WT were calculated as
fractional difference: F¼100(x-y)/y, where xmutant value and ywild type
value, at the 100 nM concentration, as follows. T138E: 100(17.0-30.4)/
30.4¼44.1%, S187E: 100(50.5-28.6)/28.6¼76.6%, T138EþS187E: 100(51.9-29.0)/
29.0¼79.0%, and S187A: 100(15.8-22.4)/22.4¼29.5%. The measurement errors
listed above, denoted here by ΔF, were calculated by propagation through F as
deﬁned above, yielding ΔF¼100[(1/y2)(Δx)2þ(x/y2)2(Δy)2]1/2, where Δx and Δy are
the published standard deviations in x and y. Values of {x, y, Δx, Δy, ΔF} are T138E:
{17.0, 30.4, 2.1, 3.6, 10.}, S187E:{50.5, 28.6, 2.9, 2.9, 21}, T138EþS187E:{51.9, 29.0,
1.5, 3.1, 20.} and S187A:{15.8, 22.4, 1.5, 4.1, 15}.
b Snap25 to Syt1: Binding afﬁnities were calculated using the in vitro binding
assays reported in Yang et al. (2007) p. 240, Figs. 6A (S187A), 6B (T138E), 6C
(S187E), and 6D (T187EþS187E), which report the relative binding percent for both
wild-type (WT) and mutated Snap25 to GST-Syt1 as functions of Snap25 concen-
tration. Changes in binding afﬁnity relative to WT were calculated as in Note “a”, at
the 100 nM concentration, as follows. T138E: 100(35.4-60.9)/60.9¼41.9%, S187E:
100(33.5-60.5)/60.5¼44.6%, T138EþS187E: 100(37.7-61.2)/61.2¼38.4%, and
S187A: 100(54.4-48.0)/48.0¼13.3%. The measurement errors listed above were
calculated as in Note “a” above. Values of { x, y, Δx, Δy, ΔF } are T138E:{35.4, 60.9,
7.1, 4.3, 12}, S187E:{33.5, 60.5, 2.8, 4.2, 6}, T138EþS187E: {37.7, 61.2, 4.9, 4.4, 9} and
S187A:{54.4, 48.0, 3.2, 4.1, 12}.
c Kataoka et al. (2011) reports: “For the S187A mutation, homozygous mutant
mice froze readily in response to environmental change, showed strong anxiety-
related behavior in general activity and light and dark preference tests, and
sometimes exhibited spontaneously occurring convulsive seizures.”4. Assessment of coupling contributions – comparison to
laboratory data
The purpose of this section is several-fold. First, an illustrative
biological process and its associated chemical interactions are
brieﬂy described. Next, the effects of mutation are evaluated in
terms of Eq. (11) in order to assess the levels of coupling con-
tributions to the binding afﬁnity. Next, coupling contributions are
similarly evaluated for two sets of mutations in other biological
processes. Lastly, pleiotropy and other effects are qualitatively
compared to Eq. (14).
4.1. Interactions associated with conduction velocity of nerve ﬁbers
Many internal organs, such as the heart, are electrically con-
nected to the nervous system, which consists of the brain, spinal
cord, and peripheral ganglia. One of the nervous system's central
physical properties is the conduction velocity of nerve ﬁbers,
which measures the propagation speed of electrical impulses. The
associated chemistry revolves around synaptic vesicles, which are
membrane-bound sacs containing neurotransmitters. Several
processes within the synaptic vesicle cycle are brieﬂy summarized
below (Südhof and Rizo, 2011).
A. Tethering – a protein on the vesicle membrane attaches to a
“tethering” protein on the pre-synaptic membrane.
B. Docking – after an initial inﬂux of Ca2þ ions, a complex forms
between the vesicle and the pre-synaptic membrane.
C. Priming – ATP binds to the vesicle membrane, making the
vesicle receptive for a Ca2þsignal.D. Fusion – after a second inﬂux of Ca2þ ions, the vesicle mem-
brane attaches to the presynaptic membrane to form a tem-
porary ion channel or pore.
E. Release – dilation of the pore leads to release of the neuro-
transmitters from the vesicle into the synapse.
F. Disassociation – the complex that attached the vesicle to the
presynaptic membrane returns to its original state.
Vesicle fusion (item “D” in the above list) involves association
and disassociation of “SNARE” proteins, where SNARE denotes
“soluble NSF attachment protein receptor” and NSF denotes “N-
ethylmaleimide-sensitive fusion protein”. Two sets of core SNARE
complexes operate in a synchronous manner, on opposite sides of
the perimeter of the vesicle-pre-synaptic membrane interface, to
create the pore through which the neurotransmitter is eventually
transferred outside the cell into the synaptic cleft (Chen and
Scheller, 2001).
Central to vesicle fusion, numerous binding events are asso-
ciated with the core SNARE complex. The core SNARE complex is a
parallel bundle of four alpha-helices, formed by binding events
among three proteins: Snap25 (Soluble NSF attachment protein),
Vamp2 (Synaptobrevin), and Stx1A (Syntaxin-1A) (Poirier et al.,
1998; Ybe et al., 2000). One alpha-helix is contributed by Vamp2
(anchored to the vesicle membrane), another alpha-helix is con-
tributed by Stx1A (anchored to the pre-synaptic membrane), and
two more alpha-helices are contributed by Snap25 (anchored to
the pre-synaptic membrane). Additionally, Syt1 (synaptotagmin-1)
binds with the core SNARE complex and Ca2þ ions to (a) activate
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closer contact with each other and/or by inducing conformational
changes in the fusion proteins, and (b) to initiate the release of
neurotransmitter (Paddock et al., 2011; Paddock et al., 2008; Bacaj
et al., 2010).
4.2. Protein–protein interactions: mutations within the SNARE
complex
Binding afﬁnity within the SNARE complex depends on the
polarity of the proteins in its central region - where a small group
of polar residues occurs among hydrophobic residues (Ybe et al.,
2000; Misura et al., 2001; Sutton et al., 1998). An appropriately
balanced strength of binding between polar residues, and between
nonpolar residues, allows the strands to be zipped when the
complex is assembled, and later unzipped when the complex is
disassembled. For example, the binding properties of core SNARE
proteins are affected by T138E and S187E mutations in Snap25 that
affect its binding afﬁnity to Stx1A and Syt1 (Yang et al., 2007)
yielding detrimental changes in phenotype (Kataoka et al., 2011).
Those mutations replace the hydroxyl group in the threonine
(T) and serine (S) residues with the negatively-charged carboxyl
group of the glutamic acid (E) residue. In the case of the S187A
mutation, the polar serine (S) residue is replaced with the non-
polar alanine (A) residue. Table 1 summarizes effects of the T138E
and S187E mutations on binding afﬁnity.
Eq. (11) has the following form when applied to isolated T138E
and S187E mutations,
ΔBðg;k;T138EÞSnap25 Stx1A ¼
XNðI;138Þcp
m ¼ 1
cðIÞ138mΔπ
ðI;T138EÞ
138m
þ1
2
XNðI;138Þcp
m;n ¼ 1
cðIÞ138m;138nΔπ
ðI;T138EÞ
138m Δπ
ðI;T138EÞ
138n ð35Þ
ΔBðg;k;S187EÞSnap25 Stx1A ¼
XNðI;187Þcp
m ¼ 1
cðIÞ187mΔπ
ðI;S187EÞ
187m
þ1
2
XNðI;187Þcp
m;n ¼ 1
cðIÞ187m;187nΔπ
ðI;S187EÞ
187m Δπ
ðI;S187EÞ
187n ð36Þ
where I  fg; k; Snap25Stx1Ag, and the following form for con-
current mutation.
ΔBðg;k;T138EþS187EÞSnapP25Stx1A ¼
XNðI;138Þcp
m ¼ 1
cðIÞ138mΔπ
ðI;T138EþS187EÞ
138m
þ1
2
XNðI;138Þcp
m;n ¼ 1
cðIÞ138m;138nΔπ
ðI;T138EþS187EÞ
138m Δπ
ðI;T138EþS187EÞ
138n
þ
XNðI;187Þcp
m ¼ 1
cðIÞ187mΔπ
ðI;T138EþS187EÞ
187m
þ1
2
XNðI;187Þcp
m;n ¼ 1
cðIÞ187m;187nΔπ
ðI;T138EþS187EÞ
187m Δπ
ðI;T138EþS187EÞ
187n
þ1
2
XNðI;138Þcp
m ¼ 1
XNðI;187Þcp
n ¼ 1
cðIÞ138m;187nΔπ
ðI;T138EþS187EÞ
138m Δπ
ðI;T138EþS187EÞ
187n
ð37Þ
Displacements ΔπðI;p-qÞ138m and Δπ
ðI;p-qÞ
187n correspond to change in
the mth and nth chemical properties centered on residues 138 and
187, respectively. Isolated mutations of residue 138 and residue
187 are represented by Eqs. (35) and (36). Concurrent mutation of
both residues is represented by Eq. (37), where the coupled con-
tribution occurs in the last term.The local chemical properties of the residues at locations 138
and 187 are affected the same regardless of whether the mutation
is concurrent (T138EþS187E) or isolated (T138E, S187E). As a
result, the following relations hold
ΔπðI;T138EþS187EÞ138m ¼ΔπðI;T138EÞ138m ð38Þ
ΔπðI;T138EþS187EÞ187m ¼ΔπðI;S187EÞ187m ð39Þ
and Eq. (37) thus simpliﬁes to the following form,
ΔBðg;k;T138Eþ S187EÞSnap25 Stx1A ¼ΔB
ðg;k;T138EÞ
Snap25Stx1AþΔB
ðg;k;S187EÞ
Snap25 Stx1A
þ1
2
XNðI;138Þcp
m ¼ 1
XNðI;187Þcp
n ¼ 1
cðIÞ138m;187nΔπ
ðI;T138Eþ S187EÞ
138m
ΔπðI;T138Eþ S187EÞ187n ð40Þ
in which the change in binding afﬁnity associated with concurrent
mutation is expressed in terms of the two isolated mutations
along with the coupling between them.
Signiﬁcant coupling contributions are evident in Table 1. The
effect of mutating residue 138 alone is a 44% decrease in binding
afﬁnity between Snap25 and Stx1A. Mutating residue 187 alone
yields a 77% increase. Therefore, acting independently, the com-
bined T138EþS187E mutation should yield a 33% increase. How-
ever, the observed result is a 79% increase, and the wide margin of
difference indicates that these two mutations are not independent.
Substituting the measured values from Table 1 into Eq. (40), after
dividing both sides by the initial (non-mutated) binding afﬁnity
yields 79%¼ 44%þ77%þx, where x¼ 46% denotes the total
coupling contribution that is the third term in Eq. (40). Similarly,
the Snap25-Syt1 interaction yields 38%¼ 42%45%þx, for
which x¼ 49%. For both interactions, the magnitude of the cou-
pling contribution (46% and 49%) is comparable to the magnitude
of each independent contribution (44%, 77%, 42% and 45%),
indicating that the coupling contributions are signiﬁcant.
The ﬁnding that coupling contributions are signiﬁcant lies well
outside the range of measurement error in Table 1. For the
Snap25-Stx1A interaction, the measurement and associated error
for T138E (44710.%) and S187E (77721%) yield the respective
ranges of uncertainty 54% to 34% and 56% to 98%. The com-
bination of those ranges has the extremes 2% to 64%, equivalent to
the range of expected values obtained by adding the measure-
ments of independent T138E and S187E mutations. In comparison,
measurement error in the concurrent mutation T138EþS187E
(79720.%) yields the range 59% to 99%, which is nearly completely
disjoint from the 2% to 64% range. Only a very small region of
overlap occurs, 59% to 64%, yielding 5 parts of 57 occurring in
common, indicating that the combined T138E and S187E mea-
surements and the T138EþS187E measurements are 88% disjoint.
Similarly, for the Snap25-Syt1 interaction associated measurement
errors for T138E (42712%) and S187E (4576%) yield
respective ranges of 54% to 30% and 51% to 39%, whose
sum yields a range of 105% to 69%. In contrast, measurement
error in the concurrent mutation (3879%) has the range 47%
to 29%, which is completely disjoint from the 105% to 69%
range. Thus for both interaction types, the range of measurements
in a sum of independent mutations is essentially disjoint from that
of a concurrent mutation, showing that the effects of coupling are
well outside the range of measurement error.
4.3. Protein-promoter interactions: Mutation to a gene's promoter
region
Early development of the kidney involves activation of glial cell
line-derived neurotrophic factor (GDNF) by several proteins, such
as the homeobox protein (Six2). Activation of GDNF by Six2 occurs
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scriptional start site, binding site 1 (BSI: motif TGTATTACA)
extends from nucleotides 279 to 253; and binding site 2 (BSII:
motif TGTAATACA – the reverse complement of the BSI motif)
extends from nucleotides 188 to 167 (Brodbeck et al., 2004).
Binding afﬁnities associated with those interactions are listed in
Table 2, along with associated changes in phenotype for mutations
to BSI and BSII. Mutations to BSI and BSII are denoted by F5m1 and
F5m2, which refer to the single substitution (ATTA - AGTA) and
the three-fold substitution (TAAT - TCCG), respectively.
When applied to F5m1 and F5m2 and using I fg; k;GDNF
Six2g, Eq. (11) takes the following form.
ΔBðg;k;F5m1þ F5m2ÞGDNFSix2 ¼
XNðI; 257Þcp
m ¼ 1
cðIÞ257mΔπ
ðI;F5m1Þ
257m þ
1
2
XNðI; 257Þcp
m;n ¼ 1
cðIÞ257m;257nΔπ
ðI;F5m1Þ
257mΔπ
ðI;F5m1Þ
257n
0
@
1
A
þ
XNðI; 184Þcp
m ¼ 1
cðIÞ184mΔπ
ðI;F5m2Þ
184m þ
1
2
XNðI; 184Þcp
m;n ¼ 1
cðIÞ184m;184nΔπ
ðI;F5m2Þ
184mΔπ
ðI;F5m2Þ
184n
0
@
1
A
þ
XNðI; 183Þcp
m ¼ 1
cðIÞ183mΔπ
ðI;F5m2Þ
183m þ
1
2
XNðI; 183Þcp
m;n ¼ 1
cðIÞ183m;183nΔπ
ðI;F5m2Þ
183mΔπ
ðI;F5m2Þ
183n
0
@
1
A
þ
XNðI; 182Þcp
m ¼ 1
cðIÞ182mΔπ
ðI;F5m2Þ
182m þ
1
2
XNðI; 182Þcp
m;n ¼ 1
cðIÞ182m;182nΔπ
ðI;F5m2Þ
182mΔπ
ðI;F5m2Þ
182n
0
@
1
A
þ
1
2
XNðI; 184Þcp
m ¼ 1
XNðI; 183Þcp
n ¼ 1
cðIÞ184m;183nΔπ
ðI;F5m2Þ
184mΔπ
ðI;F5m2Þ
183n
þ12
XNðI; 184Þcp
m ¼ 1
XNðI; 182Þcp
n ¼ 1
cðIÞ184m;182nΔπ
ðI;F5m2qÞ
184m Δπ
ðI;F5m2Þ
182n
þ12
XNðI; 183Þcp
m ¼ 1
XNðI; 182Þcp
n ¼ 1
cðg;k;GDNFSix2Þ183m;182n Δπ
ðI;F5m2Þ
183mΔπ
ðI;F5m2Þ
182n
0
BBBBBBBBBBBBB@
1
CCCCCCCCCCCCCA
þ
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XNðI; 257Þcp
m ¼ 1
XNðI; 184Þcp
n ¼ 1
cðIÞ257m;184nΔπ
ðI;F5m1þ F5m2Þ
257m Δπ
ðI;F5m1þ F5m2Þ
184n
þ12
XNðI; 257Þcp
m ¼ 1
XNðI; 183Þcp
n ¼ 1
cðIÞ257m;183nΔπ
ðI;F5m1þ F5m2Þ
257m Δπ
ðI;F5m1þ F5m2Þ
183n
þ12
XNðI; 257Þcp
m ¼ 1
XNðI; 182Þcp
n ¼ 1
cðIÞ257m;182nΔπ
ðI;F5m1þ F5m2Þ
257m Δπ
ðI;F5m1þ F5m2Þ
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0
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1
CCCCCCCCCCCCCA
ð41Þ
The BSI-speciﬁc contribution F5m1 (at location 257) occurs
within the ﬁrst parentheses, whereas the set of three concurrent
BSII-speciﬁc contributions F5m2 (at locations 184,183, and
182) occur within the next four parentheses. Contributions from
coupling between the BSI and BSII regions occur within the ﬁnal
parentheses. Eq. (41) may be simpliﬁed by recasting in terms ofTable 2
Effect of mutation in the GDNF promoter-sites on its activation by Six2.
Notation Mutation to
GDNF promoter
site(s)
Change in
binding afﬁ-
nity (%)a
Change in phenotype
F5m1 ATTA- AGTA 52717 Mutant mice show kidney
agenesis or dysgenesis and
defective enteric innervation
(Pichel et al., 1996)
BSI positions
258 to 255
F5m2 TAAT- TCCG 51719 Not available
BSII positions
185 to 182
F5m1þF5m2 both of the above 49719 Not available
a Binding afﬁnity was calculated using the transactivation assay reported in
Brodbeck et al. (2004) page 1215, Fig. 3C, which reports the level of Six2 induction
with the GDNF promoter fragments. The induction values relative to a control (1.00
fold) are as follows: F5 (1.91 fold), F5mut1 (0.39 fold), F5mut2 (0.42 fold) and
F5mut1þF5mut2 (0.48 fold). Changes in binding afﬁnity were calculated as in
Table 1 note “a”, as F5mut1: 100(0.39-1.91)/1.91¼80.%, F5mut2: 100(0.42-1.91)/
1.91¼78% and F5mut1þF5mut2: 100(0.48-1.91)/1.91¼75%. The measurement
errors listed above were calculated as in Note “a” of Table 1. Values of
{ x, y, Δx, Δy, ΔF } are F5m1:{1.39, 1.91, 0.18, 0.36, 17}, F5m2:{1.42, 1.91, 0.24,
0.36, 19} and F5m1þF5m2:{1.48, 1.91, 0.24, 0.36, 19}.the three contribution types, as follows,
ΔBðg;k;F5m1þ F5m2ÞGDNFSix2
Bo
ΔB
ðg;k;F5m1Þ
GDNFSix2
Bo
þΔB
ðg;k;F5m2Þ
GDNFSix2
Bo
þx; ð42Þ
where Bo denotes the initial (non-mutated) binding afﬁnity and x
denotes the coupling contribution (the ﬁnal parenthesis).
Combining Eq. (41) with the data in Table 2 indicates that
signiﬁcant coupling contributions are associated with the F5m1
and F5m2 mutations. When isolated, both mutations both cause
large decreases in the SIX2 binding afﬁnity: F5m1 yields a 52%
decrease and F5m2 yields a 51% decrease. If the mutations affected
binding independently, the F5m1þF5m2 mutation would yield a
much larger decrease in binding afﬁnity than either F5m1 or
F5m2. However, the measured value is only a 49% decrease. Sub-
stituting the measured values from Table 2 into Eq. (42) yields
49%¼ 52%51%þx, and thus x¼ 54%. The magnitude of the
coupling contribution (54%) is comparable to the magnitude of
each independent contribution (52% and 51%), similar to the
result for the SNARE proteins and consistent with signiﬁcant level
of coupling.
The ﬁnding that coupling contributions are signiﬁcant lies far
outside the range of measurement error in Table 2. For the F5m1–
F5m2 interaction, associated measurement error for F5m1
(52717%) and F5m2 (51719%) yields respective ranges of
uncertainty 69% to 35% and 70.% to 32%, whose sum yields
139% to 67%, equivalent to the expected values for adding the
measurements of independent F5m1 and F5m2 mutations. In
comparison, measurement error in the concurrent mutation
(49719%) yields a range of 68% to 30.%, which is almost
completely disjoint from the 139% to 67% range. Only a tiny
overlap occurs,68% to 67%, yielding 2 parts of 38 occurring in
common, that is 95% disjoint. Thus the range of measurements for
a sum of independent mutations is essentially disjoint from that of
a concurrent mutation, showing that the effects of coupling are
well outside the range of measurement error.
4.4. Protein–promoter interactions: effect of mutation on self-
activation
In addition to GDNF, a gene that is activated by the Six2 tran-
scription factor is SIX2 itself. SIX2 possesses two promoter regions:
Binding site I (denoted as Six2BSI: motif TCGGGTTA) is located at
positions 701 through 717. Binding site II (denoted as Six2BSII:
motif TAACCCGA - the reverse complement of the Six2BSI motif) is
located at positions 777 through 799. Table 3 summarizes the
effects of introducing deletions “S3Δ1” and “S3Δ2” into Six2BSI
and Six2BSII, respectively Kataoka et al. (2011), on the binding
afﬁnity between Six2 and its promoter sites.Table 3
Effect of mutations in the SIX2 promoter-site on the binding afﬁnity of Six2 self-
activation.
Notation Mutation in SIX2
promoter site(s)
Change in binding
afﬁnity (%) a
Change in
phenotype
S3Δ1 Deleted Six2BSI 4279 Not available
S3Δ2 Deleted Six2BSII 7574 Not available
S3Δ1þS3Δ2 both of the above 7174 Not available
a Binding afﬁnity was calculated from the transactivation assay reported
in Brodbeck et al. (2004) p. 1218, Fig. 5F, which reports the level of Six2 induction of
mutated SIX2 promoter fragments. The induction values are reported relative to a
control (1.0 fold). Changes in binding afﬁnity were calculated as in Table 1 note “a”,
as follows: S3Δ1: 100(10.2–17.5)/17.5¼41.9%, S3Δ2: 100(4.5-17.5)/17.5¼74.6%
and S3Δ1þS3Δ2: 100(5.2-17.5)/17.5¼70.5%. The measurement errors listed
above were calculated as in Note “a” of Table 1. Values of { x, y, Δx, Δy, ΔF } are
S3Δ1:{10.2, 17.5, 0.89, 2.14, 9}, S3Δ2:{4.50, 17.5, 0.36, 2.14, 9} and S3Δ1þS3Δ2:{5.2,
17.5, 0.36, 2.14, 4}.
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lowing form,
ΔBðg;k;S3Δ1þ S3Δ2ÞSix2 SIX20 
X717
r ¼ 701
XNðI;rÞcp
m ¼ 1
cðIÞrmΔπ
ðI;S3Δ1Þ
rm
0
@
þ1
2
X717
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X717
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XNðI;rÞcp
m ¼ 1
XNðI;sÞcp
n ¼ 1
cðIÞrmsnΔπ
ðI;S3Δ1Þ
rm Δπ
ðI;S3Δ1Þ
sn
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þ
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m ¼ 1
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cðIÞrmsnΔπ
ðI;S3Δ2Þ
rm Δπ
ðI;S3Δ2Þ
sn
!
þ 1
2
X717
r ¼ 701
X799
s ¼ 777
XNðI;rÞcp
m ¼ 1
XNðI;sÞcp
n ¼ 1
cðIÞrmsnΔπ
ðI;S3Δ1þS3Δ2Þ
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A
ð43Þ
where I fg; k; Six2SIX20g, SIX20 denotes the SIX2 promoter
region, and terms in the ﬁrst and second parentheses contain the
contributions from the independent deletions of Six2BSI and
Six2BSII, respectively. The third parenthesis contains the con-
tributions from coupling of the two deletions. The S3Δ1 and S3Δ2
mutations involve deleting all original residues, whereupon the
binding residues of Six2 presumably interact with the remaining
nucleotides in SIX20.
The data in Table 3 indicates that coupling between the S3Δ1
and S3Δ2 deletions, that is the codependent term in Eq. (43),
contributes signiﬁcantly. The change in binding associated with the
combined mutation is signiﬁcantly different from the sum of
independent S3Δ1 and S3Δ2 mutations. Substituting the measured
values from Table 3 into Eq. (43) yields 71%¼ 42%75%þx,
where x¼ 46% is the coupling contribution (the terms within the
third parenthesis). The magnitude of the coupling contribution
(46%) is comparable to the magnitude of each independent con-
tribution (42% and 75%), as it was in the two previous cases.
The ﬁnding that coupling contributions are signiﬁcant lies far
outside the range of measurement error in Table 3. For the
S3Δ1-S3Δ2interaction, associated measurement error for S3Δ1
(4279%) and S3Δ2 (7574%) yields respective ranges of
uncertainty 51% to 33% and 79% to 71%, whose sum yieldsTable 4
Six1 and Eya1: effect of mutations on binding within heterodimer.
Nucleotide mutation in
SIX1 gene
Amino acid mutation
in Six1
Change in binding a
Eya1 (%) a
C328T R110W 7974
A386G Y129C 8573
delGGA 397-399 delE133 8975
Nucleotide mutation in
EYA1 gene
Amino acid mutation
in Eya1
Change in binding a
Six1 (%) d
G1136A E330K 100711
G1325A G393S 9279
T1360C S454P 96711
T1414G L472R 100713
A1688G R514G þ3279
a Changes in binding for Six1 mutants was calculated from measurements of lacZ
reported relative to a vector, 3.7 units. Changes in binding afﬁnity were calculated as in
123¼85% and delE133: 100(13-123)/123¼89%. The measurement errors listed abov
{25.8, 123, 2.8, 16.6, 4}, Y129C:{19.3, 123, 2.8, 16.6, 3} and delE133:{12.9, 123, 6.4, 16.6,
b Branchio-otic (BO) syndrome is a developmental disorder characterized by hearin
c Branchio-oto-renal (BOR) syndrome includes the effects of BO along with malform
d Changes in binding for Eya1 mutants was calculated from measurements of lacZ
activation values are reported relative to a control, 2.6 units. Changes in binding afﬁnity
G393S: 100(2-25)/25¼92%, S454P: 100(1-25)/25¼96%, L472R: 100(0-25)/25¼10
calculated as in Note “a” of Table 1. Values of { x, y, Δx, Δy, ΔF } are E330K:{46.5, 100, 11.
100., 12.6, 5.1, 13} and R514G:{98.4, 100., 7.1, 5.1, 9}.130% to 104%, equivalent to the range of expected values for
adding the measurements of independent S3Δ1 and S3Δ2 muta-
tions. In comparison, measurement error in the concurrent
mutation (7174%) yields a range of 75% to 67.%, which is
completely disjoint from the 130% to 104% range, showing
that the effects of coupling are well outside the range of
measurement error.
4.5. Protein–protein interactions: pleiotropic and other effects
In mammalian organogenesis, the MYOG gene codes for the
myogenin protein which is essential for the development of var-
ious tissues. Myogenin is regulated by a three-protein network:
Six1 (sine oculis)-Dach (dachshund) – and Eya (eyes absent). Six1
can act as an activator or repressor owing to recruitment of the
opposing cofactors Eya (a co-activator) and Dach (a co-repressor)
(Li et al., 2003). Before birth, these interactions appear to be
essential for the normal formation of many tissues, including the
ears, kidneys and urinary tract (Abdelhak et al., 1997). Table 4
enumerates the effect of mutations in Six1 and Eya1 on binding
within the Eya1-Six1 heterodimer, along with the associated
changes in biological properties and phenotype (Ruf et al., 2004;
Buller et al., 2001).
Pleiotropic effects reported in Table 4 may be represented in a
qualitative manner using Eq. (14). For example, the L472R mutation
in Eya1 affects properties of the ears (auditory properties of the
nervous system, here indexed by kNSA ), as well as the kidneys and
urinary tract (properties of the urinary system, here indexed by kUS).
Although changes in Eya1-Six1 binding afﬁnity are identical for each
property, that is ΔB
ðg;kNSA ;L472RÞ
Eya1−Six1 =Bo ¼ ΔB
ðg;kUS ;L472RÞ
Eya1−Six1 =Bo≡−100%, the
mutations nevertheless affect widely-differing biological systems. In
terms of Eq. (14), changes in physical properties are as follows,
ΔPðg;L472RÞkNSA
¼ bðg;kNSA ÞEya1Six1ΔB
ðg;kNSA ;L472RÞ
Eya1Six1 þ
1
2
b
ðg;kNSA Þ
Eya1Six1;Eya1Six1 ΔB
ðg;kNSA ;L472RÞ
Eya1Six1
	 
2
ð44Þ
ΔPðg;L472RÞkUS ¼ b
ðg;kUS Þ
Eya1Six1ΔB
ðg;kUS ;L472RÞ
Eya1Six1 þ
1
2
bðg;kUSÞEya1Six1;Eya1Six1 ΔB
ðg;kUS ;L472RÞ
Eya1Six1
	 
2
ð45Þfﬁnity to Biological system components
affected
Change in phenotype
Ears BO b
Ears, kidneys, urinary tract BO b, BOR c
Ears BO b
fﬁnity to Biological system components
affected
Change in phenotype
Eyes Eyes only
Eyes, ears, kidneys, urinary tract BOR cþeyes (cataracts)
Ears, kidneys, urinary tract BOR c
Ears, kidneys, urinary tract BOR c
Eyes Eyes only
activation reported in Ruf et al. (2004) p. 8093 Fig. 3A. The activation values are
Table 1 note “a”, as follows: R110W: 100(26-123)/123¼79%, Y129C: 100(19-123)/
e were calculated as in Note “a” of Table 1. Values of { x, y, Δx, Δy, ΔF } are R110W:
5}.
g loss.
ations of the kidney or urinary tract.
activation in a yeast two-hybrid system, in Buller et al. (2001) p. 2776 Fig. 1C. The
were calculated as in Table 1 note “a”, as follows: E330K: 100(0-25)/25¼100%,
0% and R514G: 100(33-25)/25¼32%. The measurement errors listed above were
0, 5.1, 11}, G393S:{84.6, 100., 7.5, 5.1, 9}, S454P:{55.1, 100., 10.6, 5.1, 11}, L472R:{50.4,
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different biological properties ΔPðg;L472RÞkNSA
and ΔPðg;L472RÞkUS through the
kNSA and kUS indices. Another example of pleiotropy is the G393S
mutation in Eya1, which affects the eyes, ears, kidneys and urinary
tract. A general proof shows that Eq. (14) is consistent with pleio-
tropy (Supplementary material – Part S.5).
Table 4 also shows a complementary result - that multiple
mutations may affect the same trait, despite the mutations having
widely disparate effects on binding afﬁnity. For example, the
E330K mutation in Eya1 yields under-binding (ΔBi¼ 100%), and
the R514G mutation in Eya1 yields over-binding (ΔBi¼ þ32%), yet
the same physical property Pk and the same trait are affected
(vision-related). Such a phenomenon may be explained as two
mutations causing markedly different changes in binding afﬁnity,
with both mutations disrupting the associated chemical reaction
mechanism, and therefore yielding the same negative effect on
organ properties and traits. In terms of Eq. (14), effects of the
E330K and R514G mutations may be written as follows,
ΔPðg;E330KÞkNSO
¼ bðg;kNSO ÞEya1Six1ΔB
ðg;kNSO ;E330KÞ
Eya1Six1 þ
1
2
b
ðg;kNSO Þ
Eya1Six1;Eya1Six1 ΔB
ðg;kNSO ;E330KÞ
Eya1Six1
	 
2
ð46Þ
ΔPðg;R514GÞkNSO
¼ bðg;kNSO ÞEya1Six1ΔB
ðg;kNSO ;R514GÞ
Eya1Six1 þ
1
2
b
ðg;kNSO Þ
Eya1Six1;Eya1Six1 ΔB
ðg;kNSO ;R514GÞ
Eya1Six1
	 
2
ð47Þ
showing that the effects are appropriately ascribed to the same
physical property, PðgÞkNSO
, through the index kNSO , where NSO
denotes an optical property of the nervous system.
4.6. Assessment of coupling contributions in laboratory data:
summary
In the preceding section, three sets of laboratory data were
analyzed in terms of Eq. (11), and in each case the contribution of
coupling between entities was shown to be signiﬁcant – compar-
able in magnitude to independent contributions. The ﬁrst set of
data (Table 1) pertained to coupling between residues on the same
protein in the T138E and S187E mutations of Snap25, which affects
its binding to Stx1A and Syt1. The second set of data (Table 2)
pertained to coupling between protein residues and nucleotides of
promoter regions, in the F5m1 and F5m2 mutations to the GDNF
promoter site, which affects its activation by Six2. The third set of
data (Table 3) pertained to coupling between protein residues and
nucleotides of promoter regions in the S3Δ1 and S3Δ2 mutations
to the SIX2 promoter site, which affects self-activation of Six2.
Each instance of coupling was found to contribute signiﬁcantly to
changes in binding afﬁnity. The magnitude of the coupling con-
tributions in these cases were 16%, 35%, 54% and 50%: averaging
39%. The corresponding independent contributions were 15%, 27%,
23%, 30%, 52%, 51%, 44% and 78%: averaging 40%. Thus the average
coupling contribution (39%) differs from the average independent
contribution (40%) by only 1%.
With respect to changes in traits and phenotype, Eq. (14) was
found to be qualitatively consistent with laboratory data for
mutations to the Eya1 and Six1 heterodimer (Table 4). General
proofs show that pleiotropy and epitasis are qualitatively con-
sistent with Eqs. (11)–(18) (Supplementary material – Parts S.5
and S.6).5. Comparison of this study to the classical theory of evolution
This section presents two special cases of the ab initio model,
followed by a detailed comparison of the ab initio model to the
classical theory of evolution. The special cases are scenarios inwhich (a) entities are not shared between organs and (b) binding
afﬁnity and the physical properties of organs are continuous
functions for which limits exist with respect to small displace-
ments in chemical properties of entities. Those special cases are
shown, by deﬁnition, to correspond to the classical theory of
evolution, whose central hypothesis asserts that organs change on
an individual basis (independently) by numerous slight successive
modiﬁcations over time (Darwin, 2003a).
5.1. Absence of shared entities is equivalent to independent mod-
iﬁcation of organs
The set of physical properties used to deﬁne the phenotype Ψ g
in Eq. (4) may be separated into disjoint subsets according to
organ. For example, let one such subset ΘA correspond to the
physical properties of organ A, and let another subset ΘB corre-
spond to a different organ B, as follows.
ΘðgÞA  PðgÞA1 ; P
ðgÞ
A2
; …; PðgÞ
NðgÞα
n o
ð48aÞ
ΘðgÞB  PðgÞB1 ; P
ðgÞ
B2
; …; PðgÞ
NðgÞ
β
 
ð48bÞ
Here, PðgÞα and P
ðgÞ
β denote the α
th physical property of organ A,
and the βth physical property of organ B, respectively, and NðgÞα and
NðgÞβ denote the total number of physical properties associated with
organs A and B.
Changes in organs A and B consist of the changes in their
respective physical properties, as follows
ΔΘðg;p-qÞA  ΔPðg;p-qÞA1 ; ΔP
ðg;p-qÞ
A2
; …; ΔPðg;p-qÞ
NðgÞα
n o
ð49aÞ
ΔΘðg;p-qÞB  ΔPðg;p-qÞB1 ; ΔP
ðg;p-qÞ
B2
; …; ΔPðg;p-qÞ
NðgÞ
β
 
ð49bÞ
Through Eq. (14), each physical property change in Eqs. (49a)
and (49b) is a sum of contributions across all associated binding
interaction types, as follows for ΔPðg;p-qÞα and ΔP
ðg;p-qÞ
β .
ΔPðg;p-qÞα ¼
XNðg;αÞb
i ¼ 1
bðg;αÞi ΔB
ðg;α;p-qÞ
i þ
1
2
XNðg;αÞb
i ¼ 1
XNðg;αÞb
j ¼ 1
bðg;αÞij ΔB
ðg;α;p-qÞ
i ΔB
ðg;α;p-qÞ
j
ð50aÞ
ΔPðg;p-qÞβ ¼
XNðg;βÞb
i ¼ 1
bðg;βÞi ΔB
ðg;β;p-qÞ
i þ
1
2
XNðg;βÞb
i ¼ 1
XNðg;βÞb
j ¼ 1
bðg;βÞij ΔB
ðg;β;p-qÞ
i ΔB
ðg;β;p-qÞ
j
ð50bÞ
For example, one index may correspond to the Eya1-Six1
interaction, whereas another index may correspond to the Eya1-
Syt1 interaction, and so forth.
When no entity-type is shared between the summations of Eqs.
(50a) and (50b), ΔPðg;p-qÞα and ΔP
ðg;p-qÞ
β are independent of one
another, as follows. The set of interactions in Eq. (50a) may be
represented as set ΓA ¼ fA1A2; A3A4; …; ANA 1ANA g, and
those in Eq. (50b) may be represented as set
ΓB ¼ fB1B2; B3B4; …; BNB 1BNB g, where Ai and Bj denote
the ith and jth entity types, and NA and NB denote the total number
of entity types. If ΓA and ΓB are disjoint, it follows that mutations
to the entities in ΓA have no effect on ΔP
ðg;p-qÞ
β , and similarly
mutations in ΓB have no effect on ΔPðg;p-qÞα . In that case, no entity-
type is shared between Eqs. (50a) and (50b) and thus ΔPðg;p-qÞα and
ΔPðg;p-qÞβ are independent of one another. Given that the same
result holds for any property change in Eqs. (49a) and (49b), it
follows that organs A and B change independently when no
common entities exist. Therefore, progression of organs A and B
across generations occurs independently, provided that no shared
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(20) reduces to the following form,
ΔP0k ¼
XNg
g ¼ 1
XNðg;kÞb
i0 ¼ 1
bðg;kÞi0
XNðI′Þe
r ¼ 1
XNðI′;rÞcp
m ¼ 1
cðI′Þrm Δπ
ðI′;pg-qg Þ
rm
þ1
2
XNg
g ¼ 1
XNðg;kÞb
i′ ¼ 1
bðg;kÞi′
XNðI′Þe
r ¼ 1
XNðI′Þe
s ¼ 1
XNðI′;rÞcp
m ¼ 1
XNðI′;sÞcp
n ¼ 1
cðI′Þrmsn Δπ
ðI′;pg-qg Þ
rm Δπ
ðI′;pg-qg Þ
sn
þ1
2
XNg
g ¼ 1
XNðg;kÞb
i′;j′ ¼ 1
bðg;kÞi′j′
XNðI′Þe
r ¼ 1
XNðJ′Þe
s ¼ 1
XNðI′;rÞcp
m ¼ 1
XNðJ′;sÞcp
n ¼ 1
cðI′Þrmc
ðJ′Þ
sn Δπ
ðI′;pg-qg Þ
rm Δπ
ðJ′;pg-qg Þ
sn
ð51Þ
where the summations over interactions i0 and j0 are limited to the
particular organ associated with the kth property, and Nðg;kÞ
b0
denotes the total number of interaction-types associated with the
kth property. Aside from the constraint on interaction-types,
Eq. (51) is thus identical to Eq. (20).
The converse of the above result also holds: independent
modiﬁcation of organs implies that entities are not shared
between organs. The set of interactions associated with organ A
may be represented as before by ΓA ¼ fA1A2; A3
A4; …; ANα 1ANα g. Given that ΔPðg;p-qÞα is independent of other
organs by deﬁnition, only the interactions in ΓA are included in
ΔPðg;p-qÞα of Eq. (50a). As a result, entities associated with other
organs do not appear in ΓA, and therefore no sharing of entities
occurs between organs.
5.2. Continuous and limiting behavior in binding afﬁnity and the
physical properties of organs, with respect to changes in the chemical
properties of entities, leads to slight changes in the physical properties
of organs
Assuming the existence of arbitrarily small displacements in
the chemical properties of entities in Eqs. (9) and (10) yields the
availability of displacements such that h0rm ¼ h00rm ¼ k0sn ¼ k00sn.
Assuming further that the binding afﬁnity Bðg;kÞi ðπ
ðIÞ
rm;π
ðJÞ
snÞ is a con-
tinuous function of πðIÞrm and π
ðJÞ
sn , limits with respect to small dis-
placements of those variables may be deﬁned as c0rmðIÞ ¼ lim
hrm-0
cðIÞrm
and c0rmsnðIÞ ¼ lim
hrm ;ksn-0
cðIÞrmsn, which take the following forms.
c0ðIÞrm ¼ lim
hrm-0
Bðg;kÞi ðπ
ðIÞ
rmþhrmÞBðg;kÞi ðπ
ðIÞ
rmhrmÞ
2hrm
ð52Þc0rmsnðIÞ ¼
lim
hrm-0
Bðg;kÞi ðπ
ðIÞ
rm þhrmÞ2Bðg;kÞi ðπ
ðIÞ
rmÞþBðg;kÞi ðπ
ðIÞ
rm hrmÞ
h2rm

o
r¼ s; m¼ n
lim
hrm ;ksn-0
Bðg;kÞi ðπ
ðIÞ
rmþhrm;πðIÞsnþksnÞBðg;kÞi ðπ
ðIÞ
rmþhrm;πðIÞsnksnÞBðg;kÞi ðπ
ðIÞ
rmhrm;πðIÞsnþksnÞþBðg;kÞi ðπ
ðIÞ
rmhrm;πðIÞsnksnÞ
4hrmksn

o
ras; r¼ s; man
8>><
>>:
ð53ÞThe limits shown in Eqs. (52) and (53) have the standard forms
of partial central derivatives, namely c0rmðIÞ  lim
h-0
½f ðxþhÞ f ðxhÞ=
2h for Eq. (52), c'ðIÞrmsn≡lim
h→0
f ðxþhÞ−2f ðxÞþ f ðx−hÞ =h2) when r¼ s;
m¼ n in Eq. (53), and c0rmsnðIÞ  lim
h;k-0
½f ðxþh; yþkÞ f ðxþh; ykÞ f
ðxh; yþkÞþ f ðxh; ykÞ=4hk when r≠s; r¼ s; m≠n in Eq. (53). It
follows that the ﬁnite difference quotients in Eqs. (9) and (10)
reduce to the ordinary centered partial derivatives in Eqs. (52) and
(53). As a result, Eq. (11) becomes an ordinary Taylor series, for
which ﬁrst-order terms dominate and second-order terms become
negligible in the case of small displacements. Consequently, small
values of ΔBðg;k;p-qÞi become possible and Eq. (11) reduces to thefollowing form,
ΔB0ðg;k;p-qÞi ¼
XNðIÞe
r ¼ 1
XNðI;rÞcp
m ¼ 1
c0ðIÞrmΔπ
ðI;p-qÞ
rm ð54Þ
where the primed coefﬁcient c0ðIÞrm is the continuous analog of c
ðIÞ
rm in
Eq. (11).
A similar effect occurs in the physical properties. Continuous
limiting behavior of ΔPðgÞk with respect to small displacement in
binding afﬁnity transforms the associated ﬁnite difference quo-
tients (Supplementary material - equations (S.3.2a) and (S.3.2b))
into ordinary centered partial derivatives. As a result, second-order
contributions to ΔPðgÞk in Eq. (14) become negligible, and arbitrarily
small changes become possible in the physical properties of
organs, yielding the following.
ΔP0ðg;p→qÞk ¼ ∑
Nðg;kÞ
b
i ¼ 1
b0ðg;kÞi ∑
NðIÞe
r ¼ 1
∑
NðI;rÞcp
m ¼ 1
c0ðIÞrmΔπ
ðI;p→qÞ
rm ð55Þ
Here, the primed coefﬁcient b0ðg;kÞi0 is the continuous analog of
bðg;kÞi in Eq. (14).
5.3. Combining the two special cases leads to independent progres-
sion of organs by slight modiﬁcations over the course of time
The special case associated with the change in binding afﬁnity
given in Eq. (54) may be combined with Eq. (51), and summed
over generations as in Eq. (22), to yield the following expression
for the accumulated change in the ith binding interaction.
ΔB0ðkÞi0 ¼
XNg
g ¼ 1
XNðI0 Þe
r ¼ 1
XNðI0 ;rÞcp
m ¼ 1
c0ðI
0 Þ
rm Δπ
ðI0 ;pg-qg Þ
rm ð56Þ
Similarly, the special case associated with changes in physical
properties in Eqs. (51) and (55) may be merged into one expres-
sion. Summing that expression (not shown) over generations
according to Eq. (19) yields the following expression.
ΔP0k ¼
XNg
g ¼ 1
XNðg;kÞb
i0 ¼ 1
b0ðg;kÞi0
XNðI0 Þe
r ¼ 1
XNðI0 ;rÞcp
m ¼ 1
c0ðI
0 Þ
rm Δπ
ðI0 ;pg-qg Þ
rm ð57Þ
In Eqs. (56) and (57), the primed variable i0 indicates that the ith
interaction has no entities in common with the physical properties
of any other organ – excepting the organ associated with the kth
property. The primed coefﬁcients c0ðI
0 Þ
rm and b
0ðg;kÞ
i , denote the con-
tinuous analogs of cðIÞrm and b
ðg;kÞ
i deﬁned in Eqs. (9) and (15),
respectively.Eqs. (56) and (57) are thus consistent with the classical theory
of evolution. Eq. (56) represents the effects on binding interactions
that occur under the conditions of the classical theory. Eq. (57)
expresses the original postulate, in terms of the driving force of
mutation that is displacements in the chemical properties of
mutated entities.5.4. Comparison of the ab initio model to the classical theory of
evolution
Several fundamental differences exist between the classical
theory of evolution and the ab initio model. The central hypothesis
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numerous successive slight modiﬁcations over time (Darwin,
2003a), consistent with Eq. (57). In contrast, this study indicates
organs and their underlying chemical systems may progress
independently or interdependently, depending upon the level of
coupling, according to Eq. (20). The differences originate in the
biological level at which change to an organ is asserted to derive,
and in the magnitude of change which occurs at that level. The
classical theory places initial change at the organ (macroscopic)
level and asserts that those changes are slight, whereas this study
places initial change at the molecular level – in the chemical
properties of mutated entities – and places no constraint on the
magnitude of change. These attributes of the ab initio approach
originate from including molecular contributions, and from
including the genetic code along with the discrete nature of its
associated mutations, tantamount to incorporating scientiﬁc
achievements that have occurred since the classical theory was
developed. Including those contributions introduces a number of
implications, as follows.
(1) The classical theory holds that organs progress independently,
whereas this study indicates that organs progress with varying
degrees of interdependence. This study also indicates that
independent progression of organs is a special case in which
shared entities are absent, as shown in Section 5.1. According
to Eq. (20), evolution of organs involves modifying interde-
pendent chemical systems, for which coupling contributions
are comparable in magnitude to independent contributions.
This result is consistent with the large number of known
shared proteins, a few of which were listed in the Introduc-
tion. Empirical examples of organ interdependence include
pleiotropy in which mutation of one gene affects multiple
traits, and epistasis in which mutation of an upstream gene
affects multiple downstream organs. In both cases, organs are
coupled through shared proteins and as such may progress
interdependently.
(2) The classical theory holds that organs progress by slight mod-
iﬁcations (Darwin, 2003b), whereas this study ﬁnds that the
magnitude of change in organs is not restricted. The constraint
in the classical theory arises in the special case where behavior
is continuous rather than discrete – in both the binding afﬁnity
and an organ's physical properties - with respect to small
displacements in the chemical properties of entities, as shown
in Section 5.2. This study, in contrast, ﬁnds that displacement of
chemical properties is discrete rather than continuous, because
the mutation process usually yields a ﬁnite change in an entity's
chemical composition. Substitution within a promoter region
involves replacing one or more nucleotides with a different
nucleotide among the set of four DNA codon labels: C, A, T and
G (cytosine, adenine, thymine and guanine). Similarly, substitu-
tionwithin a protein involves replacing one or more amino acid
residues with a different residue from the set of 21 amino acid
types (or fewer than 21 in cases where the organism does not
manufacture all of them). Other mutations such as deletions
involve removing one or more entities, thereby shifting all
subsequent entities to a new location, at times yielding a
change of entity type at that new location. Thus mutations
generally involve discontinuous changes from one composition
to another, at a given location in the protein or promoter region.
In terms of Eq. (10), for example, displacement k0sn may
correspond to replacing a residue with arginine, whereas
displacement k00sn may correspond to replacing the residue with
proline. Consequently, k0sn and k
00
sn likely differ because the two
residues have different binding-related electronic properties.
Furthermore, if the binding interaction depends on those
particular residues, then the binding afﬁnities associated withk0sn and k
00
sn will differ. As a result, the ﬁrst pair of terms in the
numerator of Eq. (10), Bðg;kÞi ðπ
ðIÞ
rmþh0rm;πðJÞsnþk0snÞ and
Bðg;kÞi ðπ
ðIÞ
rmþh0rm;πðJÞsnk00snÞ, are likely nonzero when subtracted,
as are the second pair of terms Bðg;kÞi ðπ
ðIÞ
rmh00rm;πðJÞsnþk0snÞ and
Bðg;kÞi ðπ
ðIÞ
rmh00rm;πðJÞsnk00snÞ. Thus the cross terms in Eq. (10) are
likely to not vanish, hence yielding non-negligible second-order
contributions. Further, given that many electronic properties
differ widely within the sets of four nucleotides and 21 residue
types, displacements in chemical properties and the value of
the quotients in Eq. (10) should both depart signiﬁcantly from
zero. As a result, second-order contributions should generally
be signiﬁcant, and an assumption of continuous or nearly-
continuous behavior would not be an accurate approximation
for binding afﬁnity or for physical properties of an organ. The
second-order contributions are generally signiﬁcant, and there-
fore an organ may change by a small amount or large amount,
depending on the type of mutation and its associated displace-
ments in Eq. (20).
(3) The classical theory holds that gradations exist in the state of
perfection of each organ - with individual organs progressing
independently (Darwin, 2003c) and each gradation being
beneﬁcial (Darwin, 2003d), whereas this study ﬁnds that
organs progress in such a manner that the ﬁtness of the entire
organism is enhanced. Successful revision of an organ involves
successful mutation of proteins that are often shared and
hence the mutation must satisfy the constraints of multiple
chemical reactions. This constraint increases the likelihood
that an isolated mutation either yields no selective advantage
or is detrimental to an organism. Further, gradations in the
state of perfection of an individual organ may not exist apart
from that organ's ability to function within a particular
conﬁguration of organs and other components of an organism.
(4) A mutation whose displacement in chemical properties is
small, rather than large, is more likely to succeed - when
modifying an existing chemical system. Small changes in the
chemical properties of an entity, such as a small change in
polarity, are less likely to impair the interactions of that par-
ticular entity, and thus retain or improve the role of that entity
within its associated chemical reaction mechanism. Larger
changes, such as a reversal of polarity, are more likely to
require a simultaneous and commensurate change in its
binding partner to retain their binding role and thus retain the
operation of their associated chemical reaction mechanism.
For large displacements or for small concurrent displace-
ments, the likelihood of success decreases, owing to the need
for concurrent mutation in the additional entities.
(5) The likelihood of a successful mutation depends upon whe-
ther the chemical system is being modiﬁed or implemented.
When a pre-existing chemical system is modiﬁed, a single
mutation may, in principle, improve the operation of the
associated chemical reaction mechanism, and provide a selec-
tive advantage to the organism. However, when a chemical
system is implemented, only the step that completes imple-
mentation may confer a selective advantage to the organism.
As such, implementation of any of the other steps would not
yield a selective advantage, which signiﬁcantly decreases the
likelihood of successful implementation compared to the
classical theory.
(6) The probability of a successful mutation decreases with
increasing complexity of the affected chemical system. As the
number of interdependencies increases among entities and
binding interactions, the likelihood decreases that a mutated
entity may simultaneously retain and/or improve its role
within the various reactions in which it participates. For
example, a mutation in the SNARE complex may yield an
increased binding afﬁnity between the vesicle and the
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of nerve-impulse propagation (see list in Section 4.1). How-
ever, the same mutation may negatively impact the Disasso-
ciation event by impairing the ability of the SNARE complex to
return to its original state. Given that both events must remain
operational, it follows that a mutation must modify some or
possibly many of the entities involved in both events, in order
to be successful. As the number of such interdependencies
increases, so does the organ's or organism's complexity, and
the probability that a mutation simultaneously satisﬁes those
constraints necessarily decreases. This implication is consis-
tent with the classical theory which holds that organic beings
having few specialized parts are more variable in natural
selection than those standing higher in the scale (Darwin,
2003e).
(7) Differences between the ab initio model and the classical
theory increase with increasing complexity of the organism.
Such differences in the binding afﬁnity and the physical
properties of organs arise from coupling contributions to ΔBðkÞi
and ΔPk which are present in Eqs. (22) and (20) – but are not
present in Eq. (56) and (57), respectively. These coupling
contributions arise in the terms associated with different
entities and different types of binding interactions, the total
number of which provide a measure of the organism's com-
plexity. According to the upper limits of the summations in the
ﬁrst and second sets of second order contributions in Eq. (20),
the total number of off-diagonal (cross) terms is approxi-
mately 12NbNeðNe1ÞN
2
cp and
1
4NbðNb1ÞNeðNe1ÞN
2
cp, respec-
tively, the sum of which is here denoted by Nkx. Here, super-
scripts have been dropped for simplicity, Ne is the total
number of participating entities, and Ncp is the average
number of mutation-affected chemical properties per entity.
Given an average of Nk physical properties per organ, the
total number of cross terms occurring within each organ is
NkNkx. Without coupling between organs - as in the classical
theory - the total number of terms associated with Norg
organs is NorgNkNkx. By including coupling between the Nk
physical properties of each organ, 12NkðNk1ÞNkx additional
terms arise per organ pair and the total becomes NorgNkNkxþ
1
4NorgðNorg1ÞNkðNk1ÞNkx. The difference between the num-
ber of cross terms and classical terms, 14NorgðNorg1Þ
NkðNk1ÞNkx, increases with increasing Norg , Nk and Nkx. This
result, combined with the previous ﬁnding that cross (code-
pendent) terms and classical (independent) terms are compar-
able in magnitude, indicates that the difference between the
two models increases with increasing Norg , Nk, Nb, Ne, and Ncp.
The difference is qualitative, and possibly also quantitative -
depending on the degree of cancellation between the addi-
tional terms within the ab initio model. Thus the difference
between the two models increases with increasing complexity
of the organism.
The two subdivisions of evolution, micro-evolution (transitions
within species) and macro-evolution (transitions between spe-
cies), appear to relate to the level of coupling contributions. Micro-
evolution may correlate with modiﬁcation of preexisting chemical
reactions that possess a low level of functional overlap with other
chemical networks, or involve only the linear terms owing to a
small displacement in chemical properties of the affected entities.
Such scenarios correspond to higher relative probability of a suc-
cessful mutation, consistent with micro-evolution's high number
of observed instances. Similarly, macro-evolution may correlate
with high levels of coupling owing to the need to modify or
implement new molecular functionality, through chemical reac-
tions that require simultaneous change of multiple residues and
genes, or involve large displacement of chemical properties in theaffected residues, with each such scenario corresponding to low
relative probability of a successful mutation.
It is interesting to speculate on the mechanisms whereby
organs may progress in an interdependent manner. Successful
concurrent mutation could be explained by the existence of an
underlying mode of symmetry, which could act to coordinate the
mutations. Analogous phenomena are associated with elastic
properties of crystals, albeit on a much simpler scale, where dis-
placements in the position of atoms along certain directions are
interrelated by the symmetry of the crystal. In those cases,
vibrations may be expressed in terms of an irreducible set of
vibrational modes associated with the symmetry group of the
crystal. With respect to the mutational changes in physical prop-
erties of organs and binding afﬁnities of Eqs. (20) and (22), pro-
gression of an organ would be expressed in terms of an irreducible
set of mutations – possibly associated with individual species. In
order to verify the existence of an irreducible set of mutations,
much larger sets of binding assay data and transactivation analysis
data would be needed, with those sets also assessing contributions
of residues having a lesser role than binding residues, such as
those affecting kinetics, folding, and so forth.6. Discussion
The relationship between changes in an organism's phenotype
and gene mutation was studied at the molecular level using an ab
initio approach. This ﬁrst-principles method enabled the relationship
to be cast into a basic mathematical form, thereby enabling quanti-
tative assessment of the associated nonlinear effects. The approach
also enabled a simpliﬁcation whereby changes in phenotypic prop-
erties may be studied in terms of the binding afﬁnities of the che-
mical interactions affected by mutation, rather than by correlation to
the genes. Results indicate that the classical theory of evolution
occurs as a special case within the ab initio model – a case having
two attributes. First, proteins and promoter regions are not shared
between organs. Second, continuous and limiting behavior exists in
the physical properties of organs and in binding afﬁnity, with respect
to small displacements in the chemical properties of entities. Outside
of the special case, second-order coupling contributions are sig-
niﬁcant and nonlinear effects play an important role in the pro-
gression of organs, a result corroborated by analyses of published
activity levels in binding and transactivation assays. Results also
indicate the following. (a) Change in the affected organs is not
restricted in extent – an organ may change by a small amount or
large amount, depending on the type of mutation and its associated
levels of displacement and coupling. (b) Gradations in an individual
organ's state of perfection depend on the overall ﬁtness of the entire
organism, and as such the gradations are not necessarily closely-
separated. (c) A mutation is more likely to succeed when the mag-
nitude of change in the chemical properties of the entities is small
and the mutation modiﬁes an existing chemical system. (d) The
probability of a successful mutation is signiﬁcantly lower when a
chemical system is implemented, compared to when a chemical
system is modiﬁed. (e) The probability of a successful mutation
decreases with increasing complexity of the affected chemical sys-
tem. (f) Differences between the ab initio model and the classical
theory increase with increasing complexity of the organism.Acknowledgments
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